Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2013, Article ID 194932, 10 pages
http://dx.doi.org/10.1155/2013/194932
Clinical Study

Monitoring of Active Human Herpes Virus 6 Infection in Iranian Patients with Different Subtypes of Multiple Sclerosis

1Department of Neurology, Zahedan University of Medical Science, Zahedan 43181-98168-43175, Iran
2Department of Biology, Faculty of Science, Zabol University, Zabol 98613335856, Iran
3Cellular and Molecular Research Center, Tehran University of Medical Sciences, Hemmat Campus, Tehran 1449614535, Iran
4Department of Pathology, Zahedan University of Medical Sciences, Zahedan 43181-98168-43175, Iran

Received 25 July 2012; Revised 19 October 2012; Accepted 2 November 2012

Academic Editor: Timothy J. Johnson

Copyright © 2013 Nourollah Ramroodi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. de Bolle, L. Naesens, and E. de Clercq, “Update on human herpesvirus 6 biology, clinical features, and therapy,” Clinical Microbiology Reviews, vol. 18, no. 1, pp. 217–245, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Agut, “Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections,” Journal of Clinical Virology, vol. 52, no. 3, pp. 164–171, 2011. View at Publisher · View at Google Scholar
  3. D. A. Clark, “Human herpesvirus 6,” Reviews in Medical Virology, vol. 10, pp. 155–173, 2000. View at Publisher · View at Google Scholar
  4. M. Luppi, R. Marasca, P. Barozzi et al., “Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA,” Journal of Medical Virology, vol. 40, no. 1, pp. 44–52, 1993. View at Google Scholar · View at Scopus
  5. B. M. Keegan and J. H. Noseworthy, “Multiple sclerosis,” Annual Review of Medicine, vol. 53, pp. 285–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Etemadifar, M. Janghorbani, V. Shaygannejad, and F. Ashtari, “Prevalence of multiple sclerosis in Isfahan, Iran,” Neuroepidemiology, vol. 27, no. 1, pp. 39–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. H. Maghzi, M. A. Sahraian, H. Maghzi, and V. Shaygannejad, “Multiple sclerosis in Sistan and Baloochestan, South East Iran,” Clinical Neurology and Neurosurgery. In press. View at Publisher · View at Google Scholar
  8. A. Moghtaderi, F. Rakhshanizadeh, and S. Shahraki-Ibrahimi, “Incidence and prevalence of multiple sclerosis in Southeastern Iran,” Clinical Neurology and Neurosurgery. In press. View at Publisher · View at Google Scholar
  9. V. L. Stevenson, D. H. Miller, M. Rovaris et al., “Primary and transitional progressive MS: a clinical and MRI cross- sectional study,” Neurology, vol. 52, no. 4, pp. 839–845, 1999. View at Google Scholar
  10. A. Tselis, “Evidence for viral etiology of multiple sclerosis,” Seminars in Neurology, vol. 31, no. 3, pp. 307–316, 2011. View at Publisher · View at Google Scholar
  11. V. Tomsone, I. Logina, A. Millers, S. Chapenko, S. Kozireva, and M. Murovska, “Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system,” Journal of NeuroVirology, vol. 7, no. 6, pp. 564–569, 2001. View at Publisher · View at Google Scholar
  12. P. Sola, E. Merelli, R. Marasca et al., “Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunorfluorescence analysis and of viral sequences by polymerase chain reaction,” Journal of Neurology Neurosurgery and Psychiatry, vol. 56, no. 8, pp. 917–919, 1993. View at Google Scholar · View at Scopus
  13. D. V. Ablashi, H. B. Eastman, C. B. Owen et al., “Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients,” Journal of Clinical Virology, vol. 16, no. 3, pp. 179–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. K. K. Knox, J. H. Brewer, J. M. Henry, D. J. Harrington, and D. R. Carrigan, “Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease,” Clinical Infectious Diseases, vol. 31, no. 4, pp. 894–903, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. S. S. Soldan, T. P. Leist, K. N. Juhng, H. F. McFarland, and S. Jacobson, “Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients,” Annals of Neurology, vol. 47, no. 3, pp. 306–313, 2000. View at Publisher · View at Google Scholar
  16. N. Akhyani, R. Berti, M. B. Brennan et al., “Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis,” Journal of Infectious Diseases, vol. 182, no. 5, pp. 1321–1325, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. S. Kim, K. S. Lee, J. H. Park, M. Y. Kim, and W. S. Shin, “Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients,” European Neurology, vol. 43, no. 3, pp. 170–173, 2000. View at Google Scholar · View at Scopus
  18. Z. Nora-Krukle, S. Chapenko, I. Logina, A. Millers, A. Platkajis, and M. Murovska, “Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis,” Medicina, vol. 47, no. 10, pp. 527–531, 2011. View at Google Scholar
  19. S. Simpson Jr., B. Taylor, D. E. Dwyer et al., “Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis,” Multiple Sclerosis, vol. 18, no. 6, pp. 799–806, 2012. View at Publisher · View at Google Scholar
  20. P. Mirandola, A. Stefan, E. Brambilla, G. Campadelli-Fiume, and L. M. E. Grimaldi, “Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients,” Neurology, vol. 53, no. 6, pp. 1367–1368, 1999. View at Google Scholar · View at Scopus
  21. C. Taus, E. Pucci, E. Cartechini et al., “Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis,” Acta Neurologica Scandinavica, vol. 101, no. 4, pp. 224–228, 2000. View at Google Scholar · View at Scopus
  22. J. O. Virtanen and S. Jacobson, “Viruses and multiple sclerosis,” CNS and Neurological Disorders—Drug Targets, vol. 11, no. 5, pp. 528–544, 2012. View at Google Scholar
  23. D. H. Dockrell, “Human herpesvirus 6: molecular biology and clinical features,” Journal of Medical Microbiology, vol. 52, no. 1, pp. 5–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Fotheringham and S. Jacobson, “Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease,” Herpes, vol. 12, no. 1, pp. 4–9, 2005. View at Google Scholar · View at Scopus
  25. D. H. Gilden, “Infectious causes of multiple sclerosis,” The Lancet Neurology, vol. 4, no. 3, pp. 195–202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Xiong, Y. Li, F. Ni, and F. Zhang, “Monitoring of bystander effect of herpes simplex virus thymidine kinase/acyclovir system using fluorescence resonance energy transfer technique,” Journal of Biomedical Nanotechnology, vol. 8, no. 1, pp. 74–79, 2012. View at Publisher · View at Google Scholar
  27. A. Szczuciński and J. Losy, “Infectious agents in the pathogenesis of multiple sclerosis,” Przeglad epidemiologiczny, vol. 60, supplement 1, pp. 160–165, 2006. View at Google Scholar
  28. F. G. A. Moore and C. Wolfson, “Human herpes virus 6 and multiple sclerosis,” Acta Neurologica Scandinavica, vol. 106, no. 2, pp. 63–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. H. Polman, S. C. Reingold, G. Edan et al., “Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald criteria’,” Annals of Neurology, vol. 58, no. 6, pp. 840–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Sanadgol, N. Ramroodi, G. A. Ahmadi et al., “Prevalence of cytomegalovirus infection and it role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis,” New Microbiologica, vol. 34, no. 3, pp. 263–274, 2011. View at Google Scholar
  31. P. Marie, “Sclerose en plaques et maladies infectieuses,” Le Progrés Médical, vol. 12, pp. 287–289, 1884. View at Google Scholar
  32. T. Okuno, K. Takahashi, K. Balachandra et al., “Seroepidemiology of human herpesvirus 6 infection in normal children and adults,” Journal of Clinical Microbiology, vol. 27, no. 4, pp. 651–653, 1989. View at Google Scholar · View at Scopus
  33. S. S. Soldan, A. D. Goodman, and S. Jacobson, “HHV-6 and the central nervous system,” in Perspectives in Medical Virology: Human Herpesvirus-6, G. Krueger and D. V. Ablashi, Eds., pp. 213–223, Elsevier, Amsterdam, The Netherlands, 2nd edition, 2006. View at Google Scholar
  34. K. Yao, S. Gagnon, N. Akhyani et al., “Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients,” PLoS ONE, vol. 3, no. 4, Article ID e2028, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Yao, S. Honarmand, A. Espinoza et al., “Increased detection of human herpesvirus 6 in cerebrospinal fluids of patients with encephalitis of unknown origin,” Annals of Neurology, vol. 65, no. 3, pp. 257–267, 2009. View at Publisher · View at Google Scholar
  36. D. Buljevac, H. Z. Flach, W. C. J. Hop et al., “Prospective study on the relationship between infections and multiple sclerosis exacerbations,” Brain, vol. 125, no. 5, pp. 952–960, 2002. View at Google Scholar · View at Scopus
  37. Y. Mori, X. Yang, P. Akkapaiboon, T. Okuno, and K. Yamanishi, “Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46,” Journal of Virology, vol. 77, no. 8, pp. 4992–4999, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. F. G. A. Moore and C. Wolfson, “Human herpes virus 6 and multiple sclerosis,” Acta Neurologica Scandinavica, vol. 106, no. 2, pp. 63–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. K. L. Tyler, “Human herpesvirus 6 and multiple sclerosis: the continuing conundrum,” Journal of Infectious Diseases, vol. 187, no. 9, pp. 1360–1364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. S. S. Soldan, T. P. Leist, K. N. Juhng, H. F. McFarland, and S. Jacobson, “Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients,” Annals of Neurology, vol. 47, no. 3, pp. 306–313, 2000. View at Publisher · View at Google Scholar
  41. E. Caselli, M. Boni, A. Bracci et al., “Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis,” Journal of Clinical Microbiology, vol. 40, no. 11, pp. 4131–4137, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. N. B. Fredj, A. Rotola, F. Nefzi et al., “Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors,” Journal of NeuroVirology, vol. 18, no. 1, pp. 12–19, 2012. View at Publisher · View at Google Scholar
  43. A. Behzad-Behbahani, M. H. Mikaeili, M. Entezam et al., “Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis,” Journal of Microbiology, Immunology and Infection, vol. 44, no. 4, pp. 247–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Pietiläinen, J. O. Virtanen, L. Uotila, O. Salonen, M. Koskiniemi, and M. Färkkilä, “HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis,” European Journal of Neurology, vol. 17, no. 3, pp. 506–509, 2010. View at Publisher · View at Google Scholar
  45. K. I. Voumvourakis, D. K. Kitsos, S. Tsiodras, G. Petrikkos, and E. Stamboulis, “Human herpesvirus 6 infection as a trigger of multiple sclerosis,” Mayo Clinic Proceedings, vol. 85, no. 11, pp. 1023–1030, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Vinnard, T. Barton, E. Jerud, and E. Blumberg, “A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases,” Liver Transplantation, vol. 15, no. 10, pp. 1242–1246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. R. C. A. Massih and R. R. Razonable, “Human herpesvirus 6 infections after liver transplantation,” World Journal of Gastroenterology, vol. 15, no. 21, pp. 2561–2569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Garcia-Montojo, A. Martinez, V. De Las Heras et al., “Herpesvirus active replication in multiple sclerosis: a genetic control?” Journal of the Neurological Sciences, vol. 311, no. 1-2, pp. 98–102, 2011. View at Publisher · View at Google Scholar
  49. S. Chapenko, A. Millers, Z. Nora, I. Logina, R. Kukaine, and M. Murovska, “Correlation between HHV-6 reactivation and multiple sclerosis disease activity,” Journal of Medical Virology, vol. 69, no. 1, pp. 111–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Mannonen, E. Herrgård, P. Valmari et al., “Primary human herpesvirus-6 infection in the central nervous system can cause severe disease,” Pediatric Neurology, vol. 37, no. 3, pp. 186–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Khaki, A. Ghazavi, K. Ghasami et al., “Evaluation of viral antibodies in Iranian multiple sclerosis,” Neurosciences, vol. 16, no. 3, pp. 224–228, 2011. View at Google Scholar · View at Scopus
  52. R. Álvarez-Lafuente, V. Delas Heras, M. Bartolomé, J. J. Picazo, and R. Arroyo, “Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection,” Archives of Neurology, vol. 61, no. 10, pp. 1523–1527, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. M. T. Ferrò, D. Franciotta, A. Prelle, A. Bestetti, and P. Cinque, “Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis,” Journal of NeuroVirology, vol. 18, no. 5, pp. 437–440, 2012. View at Publisher · View at Google Scholar